U.S. flag

An official website of the United States government

NM_004281.4(BAG3):c.961C>T (p.Pro321Ser) AND not provided

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Aug 22, 2014
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000183320.1

Allele description [Variation Report for NM_004281.4(BAG3):c.961C>T (p.Pro321Ser)]

NM_004281.4(BAG3):c.961C>T (p.Pro321Ser)

Gene:
BAG3:BAG cochaperone 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q26.11
Genomic location:
Preferred name:
NM_004281.4(BAG3):c.961C>T (p.Pro321Ser)
Other names:
p.P321S:CCA>TCA
HGVS:
  • NC_000010.11:g.119676515C>T
  • NG_016125.1:g.30146C>T
  • NM_004281.4:c.961C>TMANE SELECT
  • NP_004272.2:p.Pro321Ser
  • NP_004272.2:p.Pro321Ser
  • LRG_742t1:c.961C>T
  • LRG_742:g.30146C>T
  • LRG_742p1:p.Pro321Ser
  • NC_000010.10:g.121436027C>T
  • NM_004281.3:c.961C>T
Protein change:
P321S
Links:
dbSNP: rs376832654
NCBI 1000 Genomes Browser:
rs376832654
Molecular consequence:
  • NM_004281.4:c.961C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000235750GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Uncertain significance
(Aug 22, 2014)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000235750.10

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

p.Pro321Ser (CCA>TCA): c.961 C>T in exon 4 of the BAG3 gene (NM_004281.3). A variant of unknown significance has been identified in the BAG3 gene. The P321S variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. P321S was not observed with any significant frequency in 6503 individuals of European and African American descent in the NHLBI Exome Sequencing Project. Missense mutations in nearby residues have not been reported indicating this region of the protein may tolerate change. However, the P321S variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Mutations in BAG3 account for approximately 2.5% of familial DCM cases (Hershberger RE and Morales A, 2013). Mutations in BAG3 may also cause myofibrillar myopathy type 6, which is characterized by early-onset, severe, progressive, diffuse muscle weakness associated with cardiomyopathy, severe respiratory insufficiency and spine rigidity (Hershberger RE and Morales A, 2013). Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. The variant is found in CARDIOMYOPATHY panel(s).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 30, 2024